
Regenerative Properties of Recombinant Human Erythropoietin in the Wound Healing
Author(s) -
Medet Toleubayev,
Mariya Dmitriyeva,
Saken Kozhakhmetov,
Nurbek Igissinov,
Dulat Turebayev,
Ardak Omarbekov,
Kairat Adaibayev,
Abylay Shakenov,
Mirsaid Izimbergenov
Publication year - 2021
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2021.5813
Subject(s) - medicine , erythropoietin , wound healing , regeneration (biology) , context (archaeology) , erythropoiesis , clinical trial , haematopoiesis , intensive care medicine , bioinformatics , anemia , surgery , stem cell , pathology , paleontology , genetics , biology , microbiology and biotechnology
BACKGROUND: Erythropoietin (EPO) is the main stimulator of erythropoiesis, but EPO also has non-hematopoietic effects. The recent data show the positive effects of EPO on tissue regeneration.AIM: This review aims to know highlights the pathophysiological mechanisms of EPO at different stages of tissue regeneration, and possible clinical applications in wound healing.METHODS: A review of the literature considering reviews, clinical studies, original papers, and articles from electronic data has been used.RESULTS: Analysis of animal studies and several clinical trials using EPO in context of wound healing revealed that EPO has a positive effect on all stages of regeneration process and may be a promising therapeutic strategy for the treatment of chronic wounds.CONCLUSION: An improved understanding of the functions and regulatory mechanisms of EPO in the context of wound healing may lead to new considerations of this growth hormone for its regular clinical application in patients.